Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Mint Medical Clinic vs RestorLife Med

Two GLP-1 desks, one scoreboard. We put Mint Medical Clinic and RestorLife Med head-to-head on the published Brief Score — the same six factors, scored the same way.

No. 208 · Grade C

Mint Medical Clinic

Visit Mint Medical Clinic Full brief →
vs
Higher Brief ScoreNo. 28 · Grade B

RestorLife Med

Visit RestorLife Med Full brief →

The verdict

RestorLife Med takes this head-to-head.

RestorLife Med scores 85 to 66 on our six-factor Brief Score — A LegitScript-certified, nationwide desk that trades a premium sticker for accreditation and clean disclosure.

That doesn't make Mint Medical Clinic a bad call — it's best for readers who want utah hybrid in-clinic plus telehealth glp-1 with broader scope. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
58
84
Supply Reliability
61
86
Transparency
88
86
Access Breadth
56
86
Clinical Oversight
70
86
Track Record
63
81
Mint Medical ClinicBrief Score 66 · 85RestorLife Med

Price, coverage & the tracker

Mint Medical ClinicRestorLife Med
Brief Score66/100 (C)85/100 (B)
SemaglutideFrom $299/mo (compounded)$299/mo
TirzepatideFrom $299/mo (compounded)$399/mo
Coverage1 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerNewnew to the tracker, no prior readingStableprice stable

Mint Medical Clinic: New to the tracker on 1 August 2026. The published line reads From $299/mo (compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

RestorLife Med: $299 sema / $399 tirz nationwide; LegitScript-certified.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.